John David Hansen's Net Worth

$268 Thousand

Estimate Recalculated Sep 8, 2024 07:32PM EST

Who is John David Hansen?

John David Hansen does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include AVANIR PHARMACEUTICALS, and MABVAX THERAPEUTICS HOLDINGS, INC..

SEC CIK

John David Hansen's CIK is 0001186123

Past Insider Trading and Trends

2017 was John David Hansen's most active year for acquiring shares with 8 total transactions. John David Hansen's most active month to acquire stocks was the month of March. 2017 was John David Hansen's most active year for disposing of shares, totalling 10 transactions. John David Hansen's most active month to dispose stocks was the month of March. 2015 saw John David Hansen paying a total of $2,077,475.00 for 1,806,500 shares, this is the most they've acquired in one year. In 2018 John David Hansen cashed out on 997,413 shares for a total of $240,784.66, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AVANIR PHARMACEUTICALS No price found

V.P. Corporate Development

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-50.00%
-30.00K
$3.41
-$102,029.76
30K
Scheduled
Jan 3
Form 4
—
0
—
—
0
Nov 10
Form 4
-33.33%
-30.00K
$3.15
-$94,518.00
60K
Scheduled
Sep 13
Form 4
—
0
—
—
0
Apr 6
No matching records found

MABVAX THERAPEUTICS HOLDINGS, INC. No price found

PRESIDENT AND CEO

John David Hansen owns 190,827 units of Common Stock. From 2014 to 2018 John David Hansen acquired a total of 1,094,789 shares in MABVAX THERAPEUTICS HOLDINGS, INC. at a cost of $7,500.50, John also disposed a total of 386,533 shares of MABVAX THERAPEUTICS HOLDINGS, INC. equalling to $275,142.09.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+4.88%
8.87K
—
—
190.83K
Apr 2
Form 4
—
0
—
—
0
Feb 21
Form 4
-9.94%
-59.26K
$0.92
-$54,521.96
536.73K
Jan 16
Form 4
+869.52%
534.52K
$0.97
-$186,262.70
595.99K
Jan 8 - Jan 12
Form 4
—
0
—
—
0
Oct 2
Form 4
—
0
—
—
0
Sep 15
Form 4
+14.85%
9.13K
$1.75
—
70.6K
May 19
Form 4
—
0
—
—
0
May 19
Form 4
-14.25%
-10.22K
$2.00
-$20,433.02
61.47K
Apr 12
Form 4
-2.02%
-1.48K
$2.00
-$2,955.33
71.69K
Apr 7 - Apr 11
Form 4
-6.46%
-5.05K
$2.17
-$10,969.08
73.17K
Apr 4 - Apr 6
Form 4
+108.41%
40.69K
—
—
78.22K
Apr 2
Form 4
—
0
—
—
0
Feb 6
Form 4
—
0
—
—
0
Jan 1
Form 4
—
0
—
—
0
Aug 29
Form 4
+9.06%
3.12K
—
—
37.53K
Aug 17
Form 4
+281.77%
187.94K
—
—
254.63K
Apr 4
Form 4
—
0
—
—
0
Feb 16
Form 4
—
0
—
—
0
Apr 2
Form 3
—
0
—
—
0
No matching records found